» Authors » Samiksha Mahapatra

Samiksha Mahapatra

Explore the profile of Samiksha Mahapatra including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 37
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hong S, Batzorig U, Fernandez-Mendez C, Chen Y, Liu Y, Mahapatra S, et al.
J Invest Dermatol . 2024 Oct; PMID: 39393506
No abstract available.
2.
Liu Y, Chen Y, Batzorig U, Li J, Fernandez-Mendez C, Mahapatra S, et al.
Immunity . 2024 Oct; 57(10):2296-2309.e5. PMID: 39353440
The surface of the skin is continually exposed to pro-inflammatory stimuli; however, it is unclear why it is not constantly inflamed due to this exposure. Here, we showed undifferentiated keratinocytes...
3.
Batzorig U, Chen Y, Liu Y, Fernandez-Mendez C, Mahapatra S, Lim S, et al.
J Invest Dermatol . 2024 Mar; 144(10):2324-2328.e4. PMID: 38555061
No abstract available.
4.
Gallicano G, Fu J, Mahapatra S, Sharma M, Dillon C, Deng C, et al.
Pharmaceuticals (Basel) . 2022 Jul; 15(7). PMID: 35890169
Causes and treatments for heart failure (HF) have been investigated for over a century culminating in data that have led to numerous pharmacological and surgical therapies. Unfortunately, to date, even...
5.
Mahapatra S, Sharma M, Brownson B, Gallicano V, Gallicano G
Mol Biol Cell . 2022 Jun; 33(11):ar96. PMID: 35653297
Myocardial fibrosis (MF), a common event that develops after myocardial infarction, initially is a reparative process but eventually leads to heart failure and sudden cardiac arrest. In MF, the infarct...
6.
Gallicano G, Casey J, Fu J, Mahapatra S
Gene Ther . 2020 Nov; 29(5):304-311. PMID: 33184504
Covid-19 (SARS CoV-2) has become a deadly, world-wide pandemic. Although most who are infected survive, complications from the virus can be pronounced and long-lasting. To date, of all the respiratory...
7.
Mahapatra S, Martin D, Gallicano G
J Stem Cells Regen Med . 2018 Jul; 14(1):10-26. PMID: 30018469
Stem cell research for treating or curing ischemic heart disease has, till date, culminated in three basic approaches: the use of induced pluripotent stem cell (iPSC) technology; reprogramming cardiac fibroblasts;...
8.
Zhang Z, Ursin R, Mahapatra S, Gallicano G
Mech Dev . 2018 Feb; 150:10-20. PMID: 29427756
Although it is well understood that genetic mutations, chromosomal abnormalities, and epigenetic miscues can cause congenital birth defects, many defects are still labeled idiopathic, meaning their origin is not yet...